STK News Alert Columbia Seligman Premium Technology (STK) 18.72

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Columbia Seligman Premium Technology (STK) 18.72 $STK

Columbia Seligman Premium Technology Growth Fund declares Q1 distribution of USD0.4625 per share
M2 - Mon Feb 09, 6:49AM CST
Columbia Seligman Premium Technology Growth Fund Inc (NYSE:STK), a closed-end investment company, announced on Friday that it will pay a first-quarter distribution of USD0.4625 per share, equal to a annual rate of 9.25% of USD20.00, the offering price in the fund's initial public offering in November 2009.
STK: 18.72 (+0.07)

Columbia Seligman Premium Technology Growth Fund Announces First Quarter Distribution: 9.25% Annual Rate for IPO Investors
Business Wire - Fri Feb 06, 10:56AM CST
Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a first-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The first-quarter distribution of $0.4625 per share is equal to a quarterly rate of 2.5567% (10.23% annualized) of the Fund's market price of $18.09 per share as of January 31, 2015.
STK: 18.72 (+0.07)

Columbia Seligman Premium Technology Growth Fund, Inc. Announces Record and Meeting Dates for Fifth Annual Meeting of Stockholders
Business Wire - Wed Jan 28, 12:19PM CST
Columbia Seligman Premium Technology Growth Fund, Inc. (the "Fund" (NYSE: STK) today announced that it will hold its Fifth Annual Meeting of Stockholders on April 13, 2015 (the "Meeting" in Minneapolis, MN. The close of business on February 26, 2015 has been fixed by the Fund's Board of Directors (the "Board" as the record date for the determination of Stockholders entitled to notice of, and to vote at, the Meeting or any postponement or adjournment thereof.
STK: 18.72 (+0.07)

Getting The Defense On The Field
Left Banker - at Seeking Alpha - Fri Jan 16, 8:47AM CST

PDI: 29.51 (unch), SPLV: 38.18 (-0.27), ETG: 16.61 (+0.10), VFC: 75.26 (+4.26), VIG: 82.39 (+0.48), WFC: 55.33 (+0.47), JTD: 16.17 (+0.02), TLT: 128.19 (-1.33), T: 34.66 (+0.05), JRI: 19.24 (+0.12), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), UTG: 31.01 (-0.73), OXLC: 15.22 (-0.12), ETY: 11.52 (+0.05), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), USMV: 41.48 (+0.03), AFL: 62.13 (+0.33), RQI: 12.36 (-0.10), SDY: 79.16 (+0.32)

Why I'm Not Closing My Position In Columbia Seligman Premium Tech Fund
Left Banker - at Seeking Alpha - Tue Jan 13, 11:34AM CST

EXG: 9.67 (+0.04), NFJ: 16.41 (-0.10), QQQ: 106.91 (+0.91), ETV: 14.67 (-0.01), IGA: 11.64 (+0.02), ETY: 11.52 (+0.05), XLK: 42.65 (+0.27), ETW: 11.79 (-0.06), STK: 18.72 (+0.07)

In Search Of Income: Covered Call CEFs (Part II - Specific Funds)
Convergence Investments - at Seeking Alpha - Wed Jan 07, 10:51AM CST

INB: 12.10 (unch), EXG: 9.67 (+0.04), NFJ: 16.41 (-0.10), IRR: 9.24 (-0.13), ETJ: 10.88 (+0.01), IGA: 11.64 (+0.02), IGD: 8.39 (+0.05), MCN: 8.36 (+0.03), BGY: 7.09 (+0.08), EOS: 14.19 (+0.11), GNT: 8.54 (+0.13), CII: 14.78 (+0.15), BOE: 13.57 (+0.08), GPM: 8.61 (+0.04), ETV: 14.67 (-0.01), FFA: 14.92 (+0.27), ETY: 11.52 (+0.05), MSP: 12.26 (+0.01), EOI: 14.05 (+0.09), ETW: 11.79 (-0.06), STK: 18.72 (+0.07), BDJ: 8.17 (-0.01)

In Search Of Income: Covered Call CEFs (Part I - Sector Analysis)
Convergence Investments - at Seeking Alpha - Tue Jan 06, 2:57PM CST

INB: 12.10 (unch), EXG: 9.67 (+0.04), NFJ: 16.41 (-0.10), IRR: 9.24 (-0.13), B: 37.40 (+0.44), ETJ: 10.88 (+0.01), IGA: 11.64 (+0.02), IGD: 8.39 (+0.05), MCN: 8.36 (+0.03), BGY: 7.09 (+0.08), EOS: 14.19 (+0.11), GNT: 8.54 (+0.13), CII: 14.78 (+0.15), BOE: 13.57 (+0.08), GPM: 8.61 (+0.04), ETV: 14.67 (-0.01), FFA: 14.92 (+0.27), ETY: 11.52 (+0.05), MSP: 12.26 (+0.01), EOI: 14.05 (+0.09), ETW: 11.79 (-0.06), STK: 18.72 (+0.07), BDJ: 8.17 (-0.01)

Update: Double-Digit Distribution Portfolio
Left Banker - at Seeking Alpha - Tue Dec 02, 2:42AM CST

PDI: 29.51 (unch), NFJ: 16.41 (-0.10), PCI: 20.56 (+0.02), IGA: 11.64 (+0.02), DVHL: 24.31 (+0.24), SDRL: 12.32 (-0.70), MORL: 19.93 (+0.09), GGN: 7.59 (+0.12), BQR: 7.57 (+0.01), EOS: 14.19 (+0.11), JRI: 19.24 (+0.12), BIT: 17.66 (-0.01), BOE: 13.57 (+0.08), EDI: 14.88 (+0.18), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), OXLC: 15.22 (-0.12), EDF: 15.46 (+0.03), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), TYG: 44.58 (+0.21)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: NHS, STK, BKH
at The Street - Wed Nov 12, 9:59AM CST
NHS STK BKH are going ex-dividend tomorrow, Thursday, November 13, 2014
STK: 18.72 (+0.07), NHS: 12.56 (+0.03), BKH: 49.01 (-0.44)

Columbia Seligman Premium Technology Growth Fund Announces Fourth Quarter Distribution: 9.25% Annual Rate for IPO Investors
Business Wire - Fri Nov 07, 11:24AM CST
Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The fourth-quarter distribution of $0.4625 per share is equal to a quarterly rate of 2.6858% (10.74% annualized) of the Fund's market price of $17.22 per share as of October 31, 2014.
STK: 18.72 (+0.07)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: STK, IEP, BPL
at The Street - Wed Aug 13, 9:05AM CDT
STK IEP BPL are going ex-dividend tomorrow, Thursday, August 14, 2014
BPL: 74.72 (+0.09), IEP: 100.21 (+0.28), STK: 18.72 (+0.07)

Columbia Seligman Premium Technology Growth Fund Announces Third Quarter Distribution: 9.25% Annual Rate for IPO Investors
Business Wire - Fri Aug 08, 10:37AM CDT
Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a third-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The third-quarter distribution of $0.4625 per share is equal to a quarterly rate of 2.7078% (10.8314% annualized) of the Fund's market price of $17.08 per share as of July 31, 2014.
STK: 18.72 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rate and Betterment's Mortgage Play: Savings or Spin?

Updated Category News Views 151

So here’s the scoop: Rate just teamed up with Betterment on February 17, 2026, offering some pretty slick mortgage incentives for those sitting on at least $100K in their investment accounts. But let’s dig into the nitty-gritty before you start dreaming of that low-rate home loan. Betterment's Strategy: Solid Gains or Hype? The partnership aims to deliver discounted...

Continue Reading
UK Water Companies Gain Confidence After Regulatory Update

Updated Category News Views 253

Morgan Stanley Highlights UK Water Sector Improvements Investment risks surrounding listed UK water companies have significantly decreased following a key regulatory decision concerning water bill increases in England and Wales. According to analysts from Morgan Stanley, this development has created a more favorable landscape for investors in the sector. Key Insights From...

Continue Reading
SiLC Technologies Unveils Advanced Eyeonic Trace Scanner

Updated Category News Views 228

SiLC Technologies Introduces Eyeonic Trace Laser Line Scanner SiLC Technologies, a leader in the development of advanced integrated FMCW LiDAR solutions, recently announced an exciting new product: the Eyeonic Trace Laser Line Scanner. This state-of-the-art Class 1 Laser Line Scanner is engineered to achieve precise measurements of objects from distances of up to 10...

Continue Reading
Accord BioPharma Launches HERCESSI™ for Cancer Treatment

Updated Category News Views 94

Accord BioPharma Announces FDA Approval for HERCESSI™ Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has achieved a major milestone in cancer treatment with the FDA's approval of a new 420mg strength of HERCESSI™ (trastuzumab-strf). This biosimilar to Herceptin (trastuzumab) targets different types of HER2-overexpressing cancers, such as...

Continue Reading
Why Oklo Stock is Soaring This Week and What to Expect

Updated Category News Views 493

What’s Driving Oklo Inc’s Stock Surge? Oklo Inc (NYSE: OKLO) is making waves in the stock market as its shares witness impressive growth. Over the past month, the company has experienced a remarkable rally of approximately 60%. Investors are keen to learn about the driving forces behind this upward trend. Recent Positive Developments This recent surge can primarily be...

Continue Reading